[8] Steele ML, Fuller S, Maczurek AE, Kersaitis C, Ooi L, Mnch G
Under the Dietary Supplement Health and Education Act (DSHEA), supplements are not required to undergo pre-market approval for efficacy
In clinical trials, semaglutide injection was shown to help people lose an average of 15% of their body weight over a period of 68 weeks
it has not received MHRA or EMA approval
Synergy with Sleep : By dosing right before bed, the BPC-157 is at peak concentration exactly when your bodys natural repair mechanisms, including fibroblast activity and GH secretion, are most active [5, 8]
Summary: AOD 9604 and retatrutide are both unlicensed investigational compounds in the UK, and there is no clinical evidence or regulatory guidance supporting their combined use